Article Sidebar

Submitted
Mar 9, 2022
Accepted
May 28, 2022
Published
Jul 5, 2022
Download
PDF
Statistic
Read Counter : 292 Download : 343

Main Article Content

Abstract

Background: The rapid spread of COVID-19 makes people anxious and afraid of this outbreak. The government has implemented policies to prevent the spread of the corona virus. One of the implementations is Large-Scale Social Restrictions. This condition causes a considerable impact on several sectors, especially health, economy and education. Objectivity: this study was to determine the characteristics of COVID-19 patients receiving treatment at Zahirah General Hospital. Material and methode: Methode of the research is observational with a cross sectional design with a total sample of 328. Result: The results showed that the most cases of COVID-19 occurred at the age Late seniors (43%), male sex as much as 52%, experiencing fever (97%), the most comorbid disease was diabetes as much as 56%, treatment carried out by giving antivirals+supplements (79%), all patients were given supplements in the form of: Acetylcysteine, Vitamin C, B-complex, Zinc, Vitamin D. Avigan/ favipiravir was the most widely used antiviral (42%), the length of time the patient was treated for 14-21 days (41%), All COVID-19 patients with comorbidities show lymphocyte levels that are lower than normal limits. Conclusion: Late seniors, men are more susceptible to COVID-19 infection, diabetes is the comorbid disease that causes death and the most severe COVID-19 symptoms, and all COVID-19 patients with comorbidities have lower lymphocyte levels

Keywords

Antiviral COVID-19 Favipivar Clinical Characteristics Remdesivir

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Author Biographies

Nur Hasanah, Widya Dharma Husada School of Health Science, South Tangerang

Pharmacy Major, Widya Dharma Husada School of Health Science, South Tangerang, Banten, Indonesia

Lela Kania Rahsa Puji, Public Health Major, Widya Dharma Husada School of Health Science

Public Health Major, Widya Dharma Husada School of Health Science, South Tangerang, Banten, Indonesia.

Nurwulan Adi Ismaya, Widya Dharma Husada School of Health Science, South Tangerang

Pharmacy Major, Widya Dharma Husada School of Health Science, South Tangerang, Banten, Indonesia.

Vini Irnia, Widya Dharma Husada School of Health Science, South Tangerang

Pharmacy Major, Widya Dharma Husada School of Health Science, South Tangerang, Banten, Indonesia.

Fenita Puranamasari Indah, Widya Dharma Husada School of Health Science, South Tangerang

Public Health Major, Widya Dharma Husada School of Health Science, South Tangerang, Banten, Indonesia

How to Cite
Hasanah, N., Puji, L. K. R., Ismaya, N. A., Irnia, V., & Indah, F. P. (2022). Profile and Clinical Character of COVID-19 Patients at Zahirah Hospital, South Jakarta: Profil dan Karakter Klinis Pasien COVID-19 di Rumah Sakit Umum Zahirah, Jakarta Selatan. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 8(2), 75-87. https://doi.org/10.22487/j24428744.2022.v8.i2.15823

References

  1. book library:
  2. RI Ministry of Health. (2020). August 2020 COVID-19 MANAGEMENT GUIDELINES. https://www.papdi.or.id/pdfs/938/Pedoman Tatalaksana COVID-19 edition 2.pdf
  3. Online ref:
  4. Ministry of health data and information center. (2021). Recovery Recovery Rate Analysis. Indonesian Ministry of Health. file:///C:/Users/DELL/Downloads/ANALYSIS-RECOVERY-RATE.pdf
  5. Journal library:
  6. Ayugun, H. (2020). Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn-Schmiedeberg's Archives of Pharmacology, 393(7), 1157–1160. https://doi.org/10.1007/s00210-020-01911-4
  7. Chen, J., Qi, T., Liu, L., Ling, Y., Qian, Z., Li, T., Li, F., Xu, Q., Zhang, Y., Xu, S., Song, Z., Zeng, Y., Shen, Y., Shi, Y., Zhu, T., & Lu, H. (2020). Clinical progression of patients with COVID-19 in Shanghai, China. Journal of Infection, 80(5), e1–e6. https://doi.org/10.1016/j.jinf.2020.03.004
  8. D, W., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - Journal of the American Medical Association, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585
  9. Disease, C., Report, S., & WHO. (2020). Coronavirus Disease Coronavirus Disease Coronavirus Disease World Health World Health Organization. World Health Organization, 19(May), 1–20.
  10. Et, order Y. (2017). Polymerase Activity (%) 100 mol / L Favipiravir Favipiravir-RMP Control. Proc Jpn Acad Ser B Phys Biol Sci., 93(7), 449–463. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713175/pdf/pjab-93-449
  11. Furuta, Y., Gowen, BB, Takahashi, K., Shiraki, K., Smee, DF, & Barnard, DL (2013). Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Research, 100(2), 446–454. https://doi.org/10.1016/j.antiviral.2013.09.015
  12. Goldhill, DH, Te Velthuis, AJW, Fletcher, RA, Langat, P., Zambon, M., Lackenby, A., & Barclay, WS (2018). The mechanism of resistance to favipiravir in influenza. Proceedings of the National Academy of Sciences of the United States of America, 115(45), 11613–11618. https://doi.org/10.1073/pnas.1811345115
  13. Hamming, I., Times, W., Bulthuis, MLC, Lely, AT, Navis, GJ, & van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for the SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathology, 203(2), 631–637. https://doi.org/10.1002/path.1570
  14. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
  15. Jia, HP, Look, DC, Shi, L., Hickey, M., Pewe, L., Netland, J., Farzan, M., Wohlford-Lenane, C., Perlman, S., & McCray, PB ( 2005). ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia. Journal of Virology, 79(23), 14614–14621. https://doi.org/10.1128/jvi.79.23.14614-14621.2005
  16. Jovic, TH, Ali, SR, Ibrahim, N., Jessop, ZM, Tarassoli, SP, Dobbs, TD, Holford, P., Thornton, CA, & Whitaker, IS (2020). Could vitamins help in the fight against covid-19? Nutrients, 12(9), 1–30. https://doi.org/10.3390/nu12092550
  17. Li, J., Gong, X., Wang, Z., Chen, R., Li, T., Zeng, D., & Li, M. (2020). Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China. Virus Research, 286, 198043. https://doi.org/10.1016/j.virusres.2020.198043
  18. McCoy, J., Wambier, CG, Herrera, S., Vaño-Galván, S., Gioia, F., Comeche, B., Ron, R., Serrano-Villar, S., Iwasiow, RM, Tayeb, MA , Cadegiani, FA, Machinekovska, NA, Shapiro, J., Sinclair, R., & Goren, A. (2021). Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. Journal of the European Academy of Dermatology and Venereology, 35(1), e15–e17. https://doi.org/10.1111/jdv.16956
  19. Setiadi, AP, Wibowo, YI, Halim, SV, Brata, C., Presley, B., & Setiawan, E. (2020). Therapeutic Management of Patients with COVID-19: A Narrative Study. Indonesian Journal of Clinical Pharmacy, 9(1), 70. https://doi.org/10.15416/ijcp.2020.9.1.70
  20. Shang, J., Wang, Q., Zhang, H., Wang, X., Wan, J., Yan, Y., Gao, Y., Cheng, J., Li, Z., & Lin, J. (2021). The Relationship Between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China. American Journal of Medicine, 134(1), e6–e14. https://doi.org/10.1016/j.amjmed.2020.05.033
  21. Skalny, AV, Rink, L., Ajsuvakova, OP, Aschner, M., Gritsenko, VA, Alekseenko, SI, Svistunov, AA, Petrakis, D., Spandidos, DA, Aaseth, J., Tsatsakis, A., & Tinkov, AA (2020). Zinc and respiratory tract infections: Perspectives for Covid-19 (Review). International Journal of Molecular Medicine, 46(1), 17–26. https://doi.org/10.3892/ijmm.2020.4575
  22. Wambier, CG, & Goren, A. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. Journal of the American Academy of Dermatology, 83(1), 308–309. https://doi.org/10.1016/j.jaad.2020.04.032
  23. Wambier, CG, Goren, A., Ossimetha, A., Nau, G., & Qureshi, A. (2020). Androgen-driven COVID-19 Pandemic Theory. SSRN Electronic Journal, April. https://doi.org/10.2139/ssrn.3571863
  24. Wang, A., Zhao, W., Xu, Z., & Gu, J. (2020). Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Research and Clinical Practice, 162, 108118. https://doi.org/10.1016/j.diabres.2020.108118
  25. Wei, X. biao, Wang, Z. hua, Liao, X. long, Guo, W. xin, Wen, JY, Qin, T. he, & Wang, S. hong. (2020). Efficacy of vitamin C in patients with sepsis: An updated meta-analysis. European Journal of Pharmacology, 868(November 2019). https://doi.org/10.1016/j.ejphar.2019.172889
  26. WHO. (2020). Diagnostic Tests for SARS-CoV-2: An interim guide. World Health Organization, September, 1–19.
  27. Yesudhas, D., Srivastava, A., & Gromiha, MM (2021). COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infections, 49(2), 199–213. https://doi.org/10.1007/s15010-020-01516-2
  28. Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020). COVID-19 pathophysiology: A review. Clinical Immunology, 215, 108427. https://doi.org/10.1016/j.clim.2020.108427